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Integrating Function-Directed Treatments into Palliative Care
Andrea L. Cheville, MD, MSCE, Melissa Morrow, PhD, Sean Robinson Smith, MD,
Jeffrey R. Basford, MD, PhDAbstractThe growing acceptance of palliative care has created opportunities to increase the use of rehabilitation services among
populations with advanced disease, particularly those with cancer. Broader delivery has been impeded by the lack of a shared
definition for palliative rehabilitation and a mismatch between patient needs and established rehabilitation service delivery
models. We propose the definition that, in the advanced cancer population, palliative rehabilitation is function-directed care
delivered in partnership with other clinical disciplines and aligned with the values of patients who have serious and often
incurable illnesses in contexts marked by intense and dynamic symptoms, psychological stress, and medical morbidity to realize
potentially time-limited goals. Although palliative rehabilitation is most often delivered by inpatient physical medicine and
rehabilitation consultation/liaison services and by physical therapists in skilled nursing facilities, outcomes in these settings have
received little scrutiny. In contrast, outpatient cancer rehabilitation programs have gained robust evidentiary support attesting to
their benefits across diverse settings. Advancing palliative rehabilitation will require attention to historical barriers to the uptake
of cancer rehabilitation services, which include the following: patient and referring physicians’ expectation that effective cancer
treatment will reverse disablement; breakdown of linear models of disablement due to presence of concurrent symptoms and
psychological distress; tension between reflexive palliation and impairment-directed treatment; palliative clinicians’ limited
familiarity with manual interventions and rehabilitation services; and challenges in identifying receptive patients with the
capacity to benefit from rehabilitation services. The effort to address these admittedly complex issues is warranted, as
consideration of function in efforts to control symptoms and mood is vital to optimize patients’ autonomy and quality of life. In
addition, manual rehabilitation modalities are effective and drug sparing in the alleviation of adverse symptoms but are markedly
underused. Realizing the potential synergism of integrating rehabilitation services in palliative care will require intensification of
interdisciplinary dialogue.Introduction
It is ironic that although the maintenance of func-
tional independence is central to the quality of life
(QoL) of patients with cancer, its loss remains poorly
recognized and undertreated [1,2]. This disjuncture
arises from a number of causes, including the fact that
physicians and patients alike often do not discuss its
occurrence in their conversations, see treatment of the
cancer as the most effective way to address its pres-
ence, and may view its progression as an inevitable
consequence of cancer. This situation is particularly
unfortunate, because effective, established, and often
relatively simple rehabilitation treatments are widely
available. An additional complication is that rehabili-
tation services tend to be more effective in the early1934-1482/$ - see front matter ª 2017 by the American Academy of Physi
http://dx.doi.org/10.1016/j.pmrj.2017.07.073stages of cancer-related functional loss, a time when
patients and clinicians are focused on treatment of the
malignancy and not the remediation of its functional
effects.
The picture is, in some ways, better in the later
stages of disease, when losses are frequently obvious
and often devastating. Oncologic clinicians and most
patients support conventional rehabilitation in hos-
pitals (eg, consultation liaison services), as well as in
postacute care settings such as inpatient rehabili-
tation facilities and skilled nursing facilities. Even
here, the picture is mixed, as rehabilitation clinicians
faced with patients with far advanced disease
may question the appropriateness providing intensive
and costly services at the terminal stages of a
disease [3].cal Medicine and Rehabilitation
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evidence that its provision improves care and lowers
costs [4], has created a climate that may provide an
opportunity for the broader integration of rehabilitation
services into the continuum of cancer care. In partic-
ular, Temel et al’s 2010 report that the provision of
palliative care to patients with newly diagnosed stage IV
lung cancer not only increased survival but also was
accompanied by improvements in their QoL and other
important clinical outcomes [5] triggered a radical
attitudinal shift. In fact, in 2016, the American Society
of Clinical Oncology published a recommendation that
all patients with advanced cancer be referred for
interdisciplinary palliative care [6]. Although subse-
quent work has not replicated palliative care’s survival
benefit, it has reinforced its ability to improve QoL and
to reduce health care use [7-9].
As yet, the growing acceptance of palliative care has
not been associated with a documented commensurate
increase in the use of rehabilitation services. Regret-
tably, functional maintenance and rehabilitation
receive only cursory mention in palliative care fellow-
ship curricula and textbooks. It is telling that less than
2% of the content the Hospice and Palliative Medicine
Board Examination relates to rehabilitation service
provision [10]. The result is that a majority of palliative
medicine practitioners have had, at best, limited
exposure to rehabilitative interventions and minimal
training in when or how to request them.
Fortunately, recognition of the importance of main-
taining functional independence has reached the point
where it is spurring widespread efforts to highlight the
need for evidence-based cancer and palliative rehabil-
itation [11,12]. This article targets the latter and is
designed to further this goal by looking at palliative care
and rehabilitation through the prism of the advanced
cancer population and doing the following: (1) proposing
a definition of “palliative rehabilitation”; (2) reviewing
palliative rehabilitation care delivery models; (3)
providing an overview of the barriers that sustain an
underuse of rehabilitation services; and (4) describing
the strengths and weaknesses of our current rehabili-
tation interventions, as well as strategies to adapt them
to palliative contexts.
Definition of Palliative Rehabilitation
Although it may seem pedantic, a definition of what
palliative rehabilitation entails is necessary to facilitate
discourse regarding its clinical and research applica-
tions. This exercise is necessary, in part, because the
field has redefined itself over the almost 50 years that
have passed since Dietz distinguished “palliative reha-
bilitation” from restorative, supportive, and preventive
rehabilitation, as function-directed care delivered to
patients with cancer in the far-advanced stages of their
illness. Effectively, patient characteristicsdprognosisand extent of diseasedwere Dietz’s proposed basis for
distinguishing “palliative” from other forms of rehabil-
itative care. In recent years, palliative medicine has
extended increasingly into earlier stages of illness, with
some advocating that it be introduced at initial diag-
nosis. This reconceptualization has expanded the pop-
ulations, contexts, and goals of palliative care such that
in its broadest view, palliative care is essentially
QoL-directed supportive care delivered at any point
along the trajectory of a progressive illness. This report
is focused on patients with advanced, and usually
incurable, oncological disease.
The peer-reviewed literature offers some indication
of the clinical situations in which the delivery of reha-
bilitation services may benefit patients with advanced
disease and/or intense or refractory symptoms. Specif-
ically, conventional conditioning and resistive exercise
can improve physical function and, in some contexts,
fatigue. However, whether general conditioning activ-
ities for high-performing patients with stage III and IV
cancer, for example, Eastern Cooperative Oncology
Group (ECOG) 0-1 patients who are experiencing little
to no manifestation or associated disablement, should
be considered “palliative rehabilitation” is question-
able. On the other hand, to confine “palliative reha-
bilitation” to function-directed services delivered to
patients who are imminently dying is to short-change its
potential.
Between these ends of the spectrum, uncertainty
persists as to where the boundaries that define and
distinguish palliative rehabilitation should be drawn. In
essence, there is no consensus as to whether palliative
rehabilitation should be defined by: (1) the character-
istics of the patients it treats, for example, prognosis,
cancer stage, level of disablement; (2) the training and
skill set of its practitioners; (3) the settings where it is
practiced, for example, a hospice; (4) the intense or
refractory nature of its therapeutic targets; (5) the
frequently limited and transient nature of its goals; or
(6) the therapeutic modalities and types of rehabilita-
tion service that are used. In summary, the goal of
clearly defining the nature of palliative rehabilitation is
not a trivial taxonomic exercise. The lack of a definition
results in poorly framed clinical discourse, unfocused
goals, and a lack of shared understanding that impairs
both care and research.
Examining what palliative rehabilitation is not
may help to establish its scope and to highlight its
unique dimensions. Palliative rehabilitation, for
example, is rarely predicated on conventional models of
impairment-driven disablement (eg, the Nagi Model in
Figure 1), which implies that disablement and handicap
are the end-products of one or a limited number of
discrete impairments. Although these models do a good
job of explaining the downstream functional conse-
quences of “single hit” focal traumatic, ischemic, and
musculoskeletal injuries, they are simplistic and poorly
Figure 1. The Nagi Model of Disability.
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ment in patients with chronic, progressive, and con-
current morbidities for whom intense symptoms,
existential distress, psychological morbidity, and frailty
all collude to degrade function.
It is also useful to consider the results of needs
assessments conducted among multi-morbid patients
with progressive illnesses [13-15]. These inventories
identify that most patients prioritize a need for help in
understanding their condition’s anticipated impact on
function, and other QoL domains. Most express a pref-
erence to remain autonomous to the extent that their
disease permits, and to protect their lay caregivers from
burnout, bankruptcy, and harm [16]. Patients desire
symptom control and psycho-emotional support. In
addition, a particularly salient desire is for providers to
consider patients’ highly unique preferences and values.
Although this latter is a priority in all rehabilitation ser-
vice delivery, the staggering rangeof individual situations
and priorities that mark palliative care in patients with
advanced cancer is a distinguishing feature.
In addition, a consideration of the skills and orien-
tation required for physiatrists to effectively meet the
needs of these patients offers some insight into the
nature of palliative rehabilitation. Palliative physiatrists
must be able to deliver care in alignment with patient
values to comprehensively address threats to patients’
waning independence with an emphasis on the
following: (1) optimizing symptoms and mood; (2)
consideration of existential issues and motivation; (3)
the particulars of disease and treatment prognoses; and
(4) integration of diverse systems of care and care-
givers. Perhaps most importantly, palliative physiatrists
must be comfortable with limited and temporary reha-
bilitation goals and intensely dynamic clinical situations
in which many critical factors may change rapidly. In
summary, it may be the shift in focus and intention, as
well as an intensity of collaboration with other disci-
plines, that most distinguishes palliative from otherforms of rehabilitation in the advanced cancer popula-
tion. The following working definition is offered as a
starting point for discourse:
Palliative rehabilitation is function-directed care
delivered in partnership with other disciplines and
aligned with the values of patients who have serious
and often incurable illnesses in contexts marked by
intense and dynamic symptoms, psychological stress,
and medical morbidity, to realize potentially time-
limited goals.Delivery Models of Cancer Rehabilitation
Tension between the potential benefits of palliative
rehabilitation and the clinical infrastructure and
delivery models that currently direct its administration
leads to a mismatch between patients’ needs and the
services available to them. Patients negotiating intense
symptoms, debilitating oncologic treatments, and
existential distress may have limited time, resources,
and energy to invest in the rehabilitation process. They
are frequently unable to repeatedly travel to outpa-
tient clinics and facilities where nonresidential reha-
bilitation services are conventionally delivered, and
identify travel requirements as a barrier [17]. Efforts
to leverage technology in the interest of developing
less time- and travel-intensive approaches have gained
some traction. However, reimbursement beyond stan-
dard rehabilitation care delivery settings remains a
challenge. Clinical contexts in which palliative reha-
bilitation may be delivered and the empirical basis for
its effectiveness in each are described in this section.
It should be noted that the citing of reports is not
intended to imply that the described interventions are
integral to palliative rehabilitation but, rather, to offer
the reader a general overview of the evidentiary basis
for providing rehabilitation services to palliative
populations.
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Rehabilitation
Skilled Nursing Facilities
Skilled nursing facilities (SNFs) are among the most
common settings for the delivery of palliative rehabili-
tation; however, to our knowledge, no reports have
described its effectiveness in this context. Because
rehabilitation service intensity and goals are relatively
less ambitious in SNF-level rehabilitation, it is theoret-
ically a good match for patients with palliative needs.
Inpatient Rehabilitation Facilities
Patients admitted to inpatient rehabilitation facil-
ities (IRFs) must have sufficient stamina to participate in
3 hours per day of therapy and a high likelihood of being
dismissed to home without the requirement for addi-
tional residential rehabilitation. This latter presents a
challenge for palliative patients who are vulnerable to
unexpected interruptions in their rehabilitation thera-
pies [18,19]. Evidence for the effectiveness of IRF-based
palliative rehabilitation is elusive. Although reports
describe comparable Functional Independent Measure
(FIM) efficiencies among patients with malignant, rela-
tive to traumatic and ischemic, brain and spinal cord
injuries, the affected patients are often individuals who
would not be conventionally characterized as “pallia-
tive,” as many continue to aggressively pursue disease-
directed therapies. To our knowledge, there are no
reports of controlled comparison of outcomes among
classically palliative patients who do and do not receive
IRF-based rehabilitation.Acute Hospital-Based Palliative RehabilitationServices provided by physical medicine and rehabili-
tation (PM&R) hospital-based consultation/liaison
services may be the most common and widespread mode
of delivering palliative rehabilitation. Such services are
delivered by highly specialized groups in comprehensive
cancer centers, as well as by PM&R generalists in com-
munity settings. No comparisons have been reported of
palliative patients who do and do not receive consulta-
tive PM&R or physical therapy (PT) services. However,
reports document improvements in pre to post compar-
isons of patients’ function after service delivery [20].Residential Hospice- and Palliative Care
WardBased Palliative RehabilitationSeveral case series described significant improvement
in pre to post PT comparisons among hospice patients
[21-23]. More recently, a randomized controlled trial
demonstrated benefits in symptom reduction, including
fatigue, among hospice residents randomized to PT
versus usual care [24].Outpatient FacilityBased Palliative
RehabilitationThe evidence supporting facility-based rehabilitation
to enhance function and other dimensions of QoL, as
well as objective performance measures, is fairly
robust, although marked by heterogeneity of samples,
settings, and interventions. This variability, in part,
explains why findings have consistently differed across
reports with respect to the magnitude of effect sizes
(ES) in different domains. For example, some studies
have detected significant improvements in fatigue,
whereas others have not [25,26]. Intervention settings
have differed substantially; including conventional
outpatient rehabilitation settings, cancer centers,
recreational facilities, and day hospices. Study samples
have also differed with respect to inclusion criteria
regarding prognosis and cancer stage. For example,
more than one-third of patients described in a case
series of center-based, posttreatment, multimodal
rehabilitation had stage III cancer, which, although
technically “late stage,” may be relatively benign [27].
In contrast, other studies have enrolled only patients
with life expectancies of 12 months or less [28]. The
diversity of intervention components is also striking.
Several reports describe multimodal interventions that
have combined exercise with nutritional or psycho-
spiritually directed components [29,30]. In contrast,
other studies have assessed interventions comprising
exercise alone [31,32]. Multi-modal interventions, in
general, have more consistently improved patient-
reported outcome (PRO) domains, although their
diversity defies broad generalizations.
Overall, however, it becomes clear that physical
exercise and multimodal rehabilitation programs have
the potential to positively affect a range of clinical
outcomes among patients with late-stage cancer.
Moreover, reports suggest that interventions may be not
only effective but may fall within conventional
willingness-to-pay thresholds [33,34].Hybrid and Home-Based Palliative
RehabilitationSeveral reports attest to the benefits of multimodal
home palliative care; however, most do not explicitly
clarify the role of rehabilitation services [35,36]. Hybrid
programs limit travel requirements andmay include 1 or 2
clinic sessions or the initiation of hospital-based therapy
followed by provision of intensive inter- or postsession
home support and instructional materials [37]. A ran-
domized trial of such a hybrid program delivered to
patients with stage IV lung and colon cancers noted
significant intergroup differences in fatigue and mobility,
favoring the intervention group [38]. Unfortunately, some
palliative patients are unable to negotiate even stream-
lined travel requirements. Telecare delivery models that
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neutralize geographic barriers have been validated in the
treatment of pain and depression [39]. A recent effort to
explore whether these approaches could be leveraged to
deliver rehabilitative services was promising. More spe-
cifically, a 42-patient pilot study of a fatigue-directed
intervention leveraged extensive prior work and
assessed the benefits of administering a behavioral inter-
vention that integrated resistive and aerobic exercisewith
mindfulness-based cognitive rehabilitation over 8 one-to-
one telephonic sessions to patients with late-stage cancer
[40-42]. This pilot work established that the intervention
had many desirable attributes: (1) multidomain effec-
tiveness: the pre-post pilot ESs were 0.48 for fatigue
interference, 0.51 for QoL, and 0.42 for physical function;
(2) high acceptability: 83% of participants (N ¼ 35)
requested continued support after completing the pilot
study; and (3) tolerability: all participants were able to
perform the recommended behaviors. In accordance with
reports in the literature, less than 15% of pilot participants
preferred in-person to telecare [43-45]. Thiswork suggests
that teledelivery may be an effective, cost-sensitive, and
patient-centric means of delivering palliative rehabilita-
tion services to patients with advanced cancer.
Barriers to the Uptake of Palliative Rehabilitation
The reasons for the underuse of rehabilitation services
in the advanced cancer population are multifactorial,
and both oncologic and rehabilitation clinicians likely
affect referral patterns. Oncologists’ attitudes toward
rehabilitation services have been characterized only to a
limited extent [3,46]. A mixed picture emerges. On one
hand, it is challenging for busy oncological clinicians to
single out issues for referral other than for discrete and
problematic clinical issues that fall outside of their scope
of expertise, such as lymphedema [47]. However, on
average, patients with late-stage cancer have multiple
physical impairments and function-degrading symptoms
for which no referrals are made. Often when patients
concurrently experience pain, depression, or anxiety
along with functional loss, they may be referred to spe-
cialists in disciplines such as pain management and psy-
chiatry, rather than rehabilitation.Patient and Referring Physicians’ Expectation
That Effective Cancer Treatment Will Reverse
DisablementReferral patterns and logistical barriers are only part of
the problem. Qualitative work on patients’ receptivity
to rehabilitation services may shed light on referring
practices as well. Cheville et al have shown that when
patients with stage III and IV lung cancer who were expe-
riencing moderate or severe (4/10 on an 11-point
numerical rating scale) functional losses and levels of
associated distress were asked if they were interested inreceiving rehabilitation services, more than two-thirds
were not [17]. The reasons for their lack of receptivity
included a desire to wait until the effects of their cancer
treatment or findings of their next scheduled imaging
studies were known, as well as general skepticism about
the benefits of rehabilitation. It was also apparent that
they assumed that since cancer was the cause of their
functional losses, that cancer treatment was the most
effective means of regaining function. This belief, unfor-
tunately, is contrary to the fact that cancer-related
disablement is progressive and persists or advances
insidiously regardless of treatment
Indeed, unrealistic expectations and concerns shared
by oncologists and other clinicians caring for patients
with advanced cancer have proved to be barriers to
rehabilitation referrals. Runacres et al found that
although oncologists viewed rehabilitation for cancer
patients favorably, and understood that palliative care
physicians did not necessarily have the requisite reha-
bilitation skillset to provide medical rehabilitation,
many oncologists were hesitant to refer advanced can-
cer patients for rehabilitation services out of concern
that it would inspire false hope in patients about their
overall prognosis [48]. Patients are often more opti-
mistic about their prognosis than oncologists, and their
caregivers often believe that oncologists do not under-
stand the extent to which patients with advanced can-
cer can recover from physical and cognitive deficits
[49,50]. An understanding of these perspectives is
essential to providing excellent palliative care, and is
perhaps why oncologists more comfortable with end-of-
life issues are more likely to refer to palliative care [51].
The idea that effective mitigation of a primary disease
process will automatically reverse its sequelae is implicit
in the biomedical model and remains so despite growing
evidence to the contrary [52,53]. The introduction of the
use of novel biologicals has resulted in the expansion of
survival times, but in turn may be associated with tox-
icities exceeding those reported in the initial clinical
trials [54]. There is a critical need for patient engage-
ment by aligning the benefits of rehabilitation services
with patients’ personal goals, and for patient and clini-
cian education regarding the need for rehabilitation
services, given the progressive nature of cancer-related
disablement despite effective anticancer treatment.Breakdown of Linear Model of Disablement Due
to Presence of Concurrent Symptoms and
Psychological DistressFunctional loss in the palliative setting is often com-
plex. Although the International Classification of Func-
tion and Disablement (ICF) (Figure 2) acknowledges
greater complexity and more contributing factors than
its earlier Nagi forerunner (Figure 1), an implicit linearity
is still present. Both models suggest that a discrete or a
limited number of impairments produce disability that,
Figure 2. International Classification of Functioning, Disability, and Health.
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contextually specific handicaps. Although these rela-
tively obvious relationships do occur in the palliative
settingdsuch as with malignant spinal cord compression
or a hemorrhagic brain metastasisdthey are not the
norm. Rather than isolated, functionally devastating
impairments, patients more often accrue multiple
impairments, with the average patient in the late stages
of cancer having upward of 5 [2]. Furthermore, work by
several groups has confirmed that pain and fatigue are
principal determinants of disablement in patients with
late-stage cancer [53]. Given this, rehabilitation efforts
that fail to adequately address clinical domains beyond
physical impairments are unlikely to succeed. Never-
theless, current models of rehabilitation service delivery
consider the relevance of these domains only to a limited
extent, for example, mood and “motivation.”
Fortunately, our ability to detect and manage these
domains in chronically ill populations has advanced
dramatically. One of the most important changes has
been the validation and clinical integration of PROs
linked to treatment recommendations. The Patient
Health Questionnaire9 (PHQ-9) is perhaps the most
salient example. The PHQ-9 was developed for depres-
sion screening in primary care settings; however, it has
now been validated in diverse clinical populations,
including patients with advanced cancer [55]. Scores
have been linked to levels of clinical acuity and man-
agement recommendations. The benefits of this exten-
sive work have been leveraged to a limited extent in
rehabilitation settings, even though depression is
prevalent among disabled cancer populations. In the
palliative setting, a failure to screen for depression with
the PHQ-9 or an alternative PRO may severely under-
mine outcomes. Management can be directed by
guidelines or per clinician discretion. The 7-item
Generalized Anxiety Disorder scale (GAD-7), similar to
the PHQ-9, is a widely used screening tool, in this case
for anxiety [56], which is also highly prevalent among
palliative populations.Similar to the efforts that have linked PHQ-9 score in-
tervals with specific treatment recommendations, work
using the Brief Pain Inventory [57] and the Patient Re-
ported Outcome Measurement Information System
(PROMIS) has identified score ranges associated with
mild, moderate, and severe levels of symptom intensity,
with well established guidelines available to inform the
management of symptom intensities across this contin-
uum. In addition to pain and fatigue, in advanced cancer
dyspnea, nausea, degraded sleep quality, and cough are
prevalent symptoms that may also be screened for
and graded using PROs. This approach permits the quan-
tification of a patient’s symptoms and allows tracking
over time to assess progression and treatment response.
Existential distress inevitably attends progressive
disablement, especially in the setting of a terminal
illness, with patients often being forced to relinquish
their defining familial, social, and vocational roles as
their illnesses progress. In the rehabilitation settings,
this process may be further hampered by clinicians’
limited familiarity or comfort with more humble goals
than lasting community and vocational reintegration.
Impactful work conducted by Chochinov et al [58] offers
clinicians and patients a way forward in their efforts to
redefine meaning and to identify and foster the essential
elements of personhood and dignity in advanced illness.Tension Between Reflexive Palliation and
Impairment/DiseaseDirected TreatmentAlthough accurate diagnosis is integral to the practice
of palliative medicine, it is often superseded by the need
to acutely relieve symptoms and distress. Frequently the
relative importance of the contributors to a patient’s
distress cannot be definitely identified in the time
available, or the required diagnostic efforts are untena-
ble or unjustified in the context of far-advanced illness.
In this manner, workup may exact unacceptable oppor-
tunity costs that delay or displace efforts to optimize
comfort. However, reflexive pharmaceutical palliation
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causes is seldom acceptable and may produce needless
side effects. Physiatrists can bring refined neuromuscular
diagnostic skills that are not routinely available in the
palliative setting and may identify previously unrecog-
nized drivers of pain and impairment. However, an
inappropriate focus on neuromuscular diagnostics can be
counterproductive, and a tension may arise between the
desire to practice impairment/diagnosisdriven reha-
bilitation and the need to acutely palliate despite diag-
nostic uncertainty. Ideally this tension can be diffused
when the expertise of palliative clinicians to systemically
alleviate suffering is paired with the neuromuscular
diagnostic precision of physiatry.
To realize potential synergism, physiatrists must
recognize the gaps in clinical care that their knowledge
and skills may bridge, and concurrently develop comfort
with the high-dose, aggressive systemic palliation that
may be required to relieve suffering. The latter may
need to be addressed, particularly in the late stages of
disease, with the use of opioids and other pharmaco-
logical agents that are controlled, potentially addictive,
and centrally acting.Palliative Clinicians’ Limited Familiarity With
Manual Interventions and Rehabilitation
ServicesThe palliative care work force is changing under the
influence of multiple factors that powerfully influence
rehabilitation service delivery. Specifically, the rate of
credentialing of new trainees is generally acknowledged
to be insufficient to meet the needs of a rapidly
expanding aged, frail, and multimorbid patient popu-
lation. This has resulted in an increasing reliance on
mid-level providers to populate palliative care teams,
predominantly nurse practitioners, physician assistants,
and clinical nurse specialists, few of whom have worked
in settings where the detection and mitigation of
disablement was an important factor. To a lesser
degree, the same lack of familiarity applies to palliative
care physicians, the significant majority of whom sub-
specialize in palliative care from general internal med-
icine, anesthesiology, family medicine, or psychiatry,
disciplines that variably emphasize functional preser-
vation in their scope of practice.
Currently, only 1% of the physicians certified in
Hospice and Palliative Medicine by the American Board
of Internal Medicine are physiatrists [59]. It is not
known how they are practicing, or the extent to which
their activities are integrated into conventional palli-
ative care services. In general, there has been limited
systematic integration of rehabilitation services into
either inpatient or outpatient palliative care or hospice
programs [48]. As a consequence, familiarizing the
palliative care work force with the potential contribu-
tions of rehabilitation medicine will continue todepend on the efforts of currently practicing physiat-
rists who may have limited experience in palliative
rehabilitation.Challenges in Identifying Receptive Patients
With the Capacity to Benefit From
Rehabilitation ServicesUnlike many of the traumatic or ischemic injuries
that cause acute and marked declines in function and
are the typical purview of rehabilitation medicine,
disablement in the palliative setting is insidiously pro-
gressive and marked by an acceleration toward the end
of life. As previously mentioned, many patients attri-
bute their functional losses to their diseases and are
willing to a limited extent to engage in the rehabilita-
tive process until their losses have become pronounced
and problematic. Unfortunately, many patients and
their treating clinicians wait until patients are hospi-
talized and disablement has progressed to the point of
impeding home dismissal. This approach results in
needless institutionalization and becomes even less
acceptable in light of spiraling costs and patient
numbers. However, 2 elements vital to creating a
credible alternative have not yet enjoyed broad clin-
ical uptake. These include systematic screening for
functional decline, and proactive effort on the part of
oncology care teams to make functional preservation
an integral part of comprehensive cancer care. Ad-
vances in PRO-based functional assessment offer the
potential to create unprecedentedly precise and effi-
cient measures to screen for subtle changes in patient
functioning over time. This work continues to advance,
as described in the next paragraph, but its impact re-
mains limited.
A brief description of ongoing efforts to enhance PRO-
based functional assessment is warranted, because these
approaches offer a pragmatic means of identifying and risk
stratifying patients experiencing disablement, and item
response theorybased instruments now permit the rapid
assessment of latent traits such as mood and pain, which
cannotbeobjectively assessed.Atpresent, 2 itemresponse
theorymodeled item banks that evaluate function have
been studied in cancer populations: the Activity Measure
for Post-Acute Care and the PROMIS function bank, both of
which can be administered with greater efficiency and
precision using a computer adaptive testing platform. Of
these, the Basic Mobility Activity Measure for Post-Acute
Care item bank has been psychometrically characterized
among patients with advanced-stage cancer and shown to
be valid and responsive [53]. The goal of embedding func-
tional screening in routine oncology and palliative care
delivery pathways may become far more feasible in the
near term, because the latest versions of many electronic
health records include the capability to administer item
banks via computer adaptive testing.
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Principles in Palliative Care
Palliative rehabilitation services are most consistently
engaged in acute care hospital settings. This reflects the
disproportionate expansion of inpatient, relative to
outpatient, palliative care, with most teaching hospitals
now providing some form of palliative care subspecialty
services. Rehabilitation’s pragmatic focus on function
complements the emphasis on symptom management
and goal setting that characterizes palliative care.
An important consideration is that since US hospices
are overwhelmingly home based, patients and their
caregivers are understandably concerned about negoti-
ating the transition from a hospital setting to home, and
the requirements of feeding, toileting, and other daily
activities. Such mundane concerns are often over-
shadowed by concerns regarding whether to continue
oncology-directed treatment, how to manage refractory
pain, code status, and so forth. Rehabilitation special-
ists are uniquely equipped to foster the concrete,
practical discussions that explore the small essential
concerns, such as how and whether to use a gait aid or
how to get out of the house, that determine the sub-
stance of patients’ lives as they grapple with larger is-
sues. What follows is a brief guide for the rehabilitation
consultant with suggestions for how to appropriately
target issues common among patients in the palliative
stages of illness.Pain ManagementPalliative care clinicians are analgesic experts but
may not fully recognize the need to address movement-
associated pain that powerfully degrades patients’
function and autonomy. Bone metastases are the most
prevalent source of cancer-related pain [60]. Inevi-
tably, loading or moving the affected structures pro-
vokes pain. Immobility is the easiest way to avoid pain,
and most patients’ default in the absence of appro-
priate education on how to use their analgesics stra-
tegically to control movement-associated pain.
Because many patients have diminished pain at rest,
the use of long-acting agents to control their incident,
movement-associated pain results in overmedication.
Lower doses and improved control can be achieved by
anticipating intervals of increased movement and pre-
medicating with an adequate dose of a “normal”- or
“immediate”- release opioid or nonsteroidal anti-
inflammatory drug, more often the former. The dose
required can be established through an iterative trial-
and-error process with the understanding that re-
quirements are dynamic and will change over time. All
naturally occurring and semisynthetic opioids, for
example, morphine, oxycodone, and hydrocodone,
require 30-45 minutes after ingestion before takingeffect. In contrast, purely synthetic fentanyl is highly
lipophilic, and transmucosal preparations can take ef-
fect in 3-5 minutes. Unfortunately, these agents are
costly, and the requirement for Transmucosal Immedi-
ate Release Fentanyl Risk Evaluation and Mitigation
Strategy program certification to prescribe them have
restricted access.
Rather than suggesting specific agents or doses, the
role of the rehabilitation clinician in managing
movement-associated pain is usually 2-fold. First, there
is a need to discuss strategic approaches for managing
incident pain with the referring primary or palliative care
service, with emphasis on the critical need to synchro-
nize periods of movement with the analgesic’s serolog-
ical peak. Second, it is critical to promote understanding
of the strategy across all relevant stakeholders including
patients, caregivers, nurses, physical and occupational
therapists, as well as the relevant medical services.
Educating both the patient and the family is essential,
given that they will be required to execute the strategy
after hospital discharge. Perhaps most importantly, the
patient should be afforded the freedom to experiment,
because pain distribution, intensity, and provoking
movements will inevitably change over time.Positioning and De-weighting to Control PainGait aids, positioning, foam bolsters, seat cushions,
mattress overlays, and the many other devices used to
remove pressure from painful structures are underused
in general palliative care. Cachexia is common among
patients with advanced disease, and pressure on bony
prominences can provoke pain that may prove
refractory to even high-dose opioid analgesia. Simple
de-weighting techniques, including regular reposition-
ing, offer an inexpensive and often remarkably effec-
tive means of addressing focal, pressure-related pain.
Approaches are inevitably individual, and generalized
prescriptive recommendations are of limited value.
More importantly, rehabilitative clinicians should
remember to check for opportunities to apply their
expertise in seating, offloading, and de-weighting,
even when they have not been consulted for this
purpose.OrthoticsOrthotics are similarly underused in the palliative
setting, with the exception of clamshell-type thor-
acolumbosacral orthoses, which are often reflexively
ordered to control back pain. Several overarching prin-
ciples should guide palliative orthotic prescription. The
following recommendations are based on anecdotal
experience, as there is little evidence base to direct
clinical decision making. First, comfort is paramount,
even when a patient’s spine may be in future jeopardy.
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sive, poorly tolerated by patients, and inconsistently
covered by third-party payers, effort should be invested
in determining whether it will enhance comfort. Diffi-
culty in putting on and taking off, chafing, focal
constriction, and so forth are all common issues that
undermine the stated treatment goal. The availability
of off-the-shelf or loaner models that patients can trial
without a costly investment are an asset. Second,
patients’ future status must be anticipated. Weight loss
and gain, edema, progressive weakness, and other is-
sues may render an effective orthotic relatively useless
in a short period of time. Patients’ anticipated func-
tional abilities and goals may or may not align with the
need for an orthotic. Finally, if a patient is dismissing to
hospice or home, the requirement for an orthotic and
granular prescription details should be explicitly
documented.EdemaFocal or generalized edema is highly prevalent and is
an important source of discomfort and disablement in
palliative populations. Contributing factors such as
organ failure, hypoalbuminemia, venous obstruction,
and lymphatic blockage tend to make the resultant
swelling dynamic and refractory. In addition, cardiac
and renal failure may impede mobilization and elimi-
nation of fluid once returned to the intravascular space.
In the palliative context, prudent use of diuretics may
be highly beneficial. This contrasts with the conven-
tional management of lymphedema and venous stasis
edema, where diuretic use is discouraged. Use of
compression garments may be ineffective, given
ongoing shifts in fluid volume and distribution, as well
as challenges in putting these on. Multilayer short
stretch bandaging can generally accommodate such
shifts, but is laborious for caregivers and may be un-
tenable for patients with limited assistance. Alternative
Velcro-based compression devices such as the Compre-
fit (BiaCare, Zeeland, MI) and Juxta-fit (mediUSA,
Whitsett, NC) adjustable garments often represent the
most convenient and effective management option
[61]. However, even the most rudimentary of these
garments are not inexpensive, and coverage varies
across payers.Activities of Daily Living and MobilityOptimizing safety and autonomy during a patient’s
activities of daily living (ADLs) in the palliative setting
differs little from other contexts, with the exception of
one important caveat: patients’ functional capabilities
are dynamically declining, and effective management
must anticipate their condition over the weeks to
months ahead. This is not a simple task, given the
staggering heterogeneity of cancer types andtreatments. In addition, many patients are, even when
confronting far-advanced illness, hoping to improve,
and may not welcome candid discussions of their
impending disablement. Clinicians must perform a
delicate balancing act of providing patients and their
caregivers with the knowledge, skills, and equipment
needed to preserve autonomy, without triggering alarm,
rejection, or denial.Hospice and Rehabilitation ServicesHospice providers may vary in the available hours of
home health assistance, respite care policies, patient
bathing and toileting, and support in other household
maintenance tasks. Rehabilitation clinicians, with their
keen awareness of task requirements, can play an
invaluable role in assisting patient and their families in
the selection of a hospice provider. It should be
remembered that, at times, hospice may offer fewer
services than traditional home care; therefore, it is
essential to consider patient and family needs on a case-
by-case basis. Most hospices offer expert management
of symptoms, existential distress, anticipatory grief,
mood disorders, and other concerns prevalent at the
end of life. If such issues are anticipated, hospice may
be the best option. However, hospice need not be the
reflexive go-to in provision of home services for terminal
patients.
Hospice providers are required to comprehensively
address patients’ needs. However, as mentioned previ-
ously, rehabilitation needs may be overshadowed unless
the hospital-based rehabilitation team carefully high-
lights and outlines the patients’ equipment, orthotic,
and therapy needs as well as encouraging caregivers to
advocate to ensure that recommendations are followed.
This applies irrespective of whether patients dismiss to
home or residential hospice facilities.
Rehabilitation clinicians, with their insights into
patient functioning, and caregivers’ ability to safely
provide assistance can contribute invaluably to decision
making in dismissal planning as well as to whether a
patient requires residential hospice. Hospice services
may be provided in skilled nursing facilities or hospice
homes. In either case, unless a patient is covered by
Medicaid, has long-term care insurance, or is Veterans’
Administration affiliated, out-of-pocket expenses can
be substantial. Assisting primary, palliative, and social
service workers to sort through conflicting priorities in a
hospice dismissal setting is a much appreciated role
that rehabilitative providers are uniquely equipped to
fulfill.
Recommendations for Physiatrists Providing
Palliative Rehabilitation
Only a limited evidence base is available to guide
palliative physiatrists, but the experiences of seasoned
S344 Integrating Function-Directed Treatments Into Palliative Careclinicians provide some insights and are the basis for the
following recommendations. First, establish and nurture
a supportive relationship. This may involve learning the
particulars of a patient’s home life as well as the
patient’s functional goals and expectations. Often
patients and their caregivers, fatigued by complex
treatment-related discussions, welcome simple and
concrete exchanges about the accessibility of their
home, getting into and out of their vehicle, and local
sources of support. It is important to gain an under-
standing of how patients and caregivers perceive their
current and future functional capabilities. A focus on
current abilities and ensuring safety for patients as well
as their caregivers may enable patients to maintain
dignity while accepting assistance.
Second, gingerly initiate discussion about a patient’s
potential use of hospice care, or other home services,
focusing on who may be with the patient, their level of
health and function, and potential pitfalls. Problem
solving theoretical barriers may afford enough
emotional distance that patients and caregivers are able
to engage without feeling threatened or overwhelmed.
Describing patients’ performance in objective terms,
whether they are improving or declining, creates a basis
for discussion about dismissal location and the extent to
which caregivers may safely manage at home. Encour-
aging caregivers to actively assist nurses and therapists
in mobilizing the patient not only provides vital insight
into the difficulties that they may face at home, but
offers opportunities to promote safe biomechanics,
engage caregivers in equipment selection, and highlight
challenging task sequences or components.
Third, proceed cautiously in preparing patients and
caregivers for the declines that lie ahead. How far to
pursue discussions of future needs is a contextual and
highly practitioner-dependent decision. Patients expect
to learn their prognoses from their oncologists and are
understandably disturbed when information is not
delivered consistently across services [62]. It is there-
fore vital that palliative physiatrists have an up-to-date
and accurate understanding of what information has
been relayed and by whom regarding prognosis and
dismissal planning. If patients and/or caregivers are
unable to engage in “what to do in the event of .”
discussions, then developing a plan that includes
frequent reassessment and access to rehabilitation
services is critical. Often, even if patients are willing
and able to have these difficult conversations, all
possible contingencies cannot be addressed. Informing
patients and caregivers that help is available, and
encouraging them have a low threshold to ask for help,
is often the best that one can do.
Conclusion
Palliative rehabilitation is a growing need that
remains severely underaddressed. Whether and howPM&R rises to the challenge of caring for the expanding
population of seriously ill, disabled patients will define
the future of the field. The issue is a national priority and
should prompt physiatrists and other rehabilitation
specialists to question whether the field’s scope should
be guided by tradition, reimbursement, or patient need.References
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